Home >> Marketplace Directory >> Horizon, ArcherDX sign OEM agreement, 6/15

Horizon, ArcherDX sign OEM agreement, 6/15

image_pdfCreate PDF

June 2015—Horizon Discovery Group and ArcherDX have signed an original equipment manufacturer agreement in which Horizon’s reference materials will be supplied as a standalone product alongside ArcherDX’s Archer FusionPlex to aid customer validation of its ALK fusion assay kits. The ALK fusion tests can run on both Illumina and Ion Torrent next-generation sequencing platforms.

The Archer FusionPlex ALK, RET, ROS1 Panel simultaneously detects and identifies both known and previously unidentified fusions and mutations of human ALK, RET, and ROS1 (c-ros oncogene 1) genes from tumor samples, including formalin-fixed, paraffin-embedded preserved specimens.

Horizon Discovery Group, +44 (0) 20 3709 5701

CAP TODAY
X